Volume | 16,853,474 |
|
|||||
News | - | ||||||
Day High | 0.0011 | Low High |
|||||
Day Low | 0.0009 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Therapeutic Solutions International Inc (PK) | TSOI | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0011 | 0.0009 | 0.0011 | 0.001 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
93 | 16,853,474 | $ 0.00093 | $ 15,675 | - | 0.0009 - 0.0082 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:53:34 | 1,000,000 | $ 0.001 | USD |
Therapeutic Solutions International Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 3.09M | 3.09B | 303.59M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Therapeutic Solutions (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TSOI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0011 | 0.0012 | 0.0009 | 0.0010193 | 30,063,978 | -0.0001 | -9.09% |
1 Month | 0.0013 | 0.0016 | 0.0009 | 0.001164 | 16,470,837 | -0.0003 | -23.08% |
3 Months | 0.0016 | 0.0022 | 0.0009 | 0.0013961 | 14,749,246 | -0.0006 | -37.5% |
6 Months | 0.0024 | 0.0025 | 0.0009 | 0.0015199 | 13,512,480 | -0.0014 | -58.33% |
1 Year | 0.0075 | 0.0082 | 0.0009 | 0.0024449 | 12,586,329 | -0.0065 | -86.67% |
3 Years | 0.0053 | 0.172925 | 0.0009 | 0.0286091 | 9,711,695 | -0.0043 | -81.13% |
5 Years | 0.0033 | 0.172925 | 0.0007 | 0.0195985 | 9,985,810 | -0.0023 | -69.7% |
Therapeutic Solutions (PK) Description
Therapeutic Solutions International, Inc. is involved in the medical sciences market. We are focused on three different areas within the same market. They are outlined as follows: 1. Dietary Supplements 2. Immunotherapy Our business plan is twofold: 1. Produce and refine current product lines and develop them further, and 2. To focus on leveraging immunological processes to diagnose and intervene in niche areas of unmet medical needs. |